
Menu
HOME
cialis half life
cialis free sample canada
mix cialis viagra
cialis why two bathtubs
what is better viagra or cialis
prostate cancer cialis
buy cialis in london
compare cialis and levitra
cialis the dangers fda
|
cialis confusion
In the 1-year open label extension study, back pain and myalgia were reported in 5.5% and 1.3% of patients, respectively. It is not possible to determine whether these events are related directly to Cialis, to sexual activity, to the patient's underlying cardiovascular disease, to a combination of these factors, or to other factors .
Body as a whole — hypersensitivity reactions including urticaria, Stevens-Johnson syndrome, and exfoliative cialis confusion — migraine, seizure and seizure recurrence, transient global amnesia
Ophthalmologic — visual field defect, retinal vein occlusion, retinal artery occlusion
Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely postmarketing in temporal association with the use of phosphodiesterase type 5 (PDE5) inhibitors, including Cialis. The list does cialis confusion include adverse events that are reported from clinical trials and that are listed elsewhere in this section.
Cardiovascular and cerebrovascular — Serious cardiovascular events, including myocardial infarction, sudden cardiac death, stroke, chest pain, palpitations, and tachycardia, have been reported postmarketing in temporal association with the use of tadalafil. It is not possible to determine whether these cialis confusion events are related directly to the use of tadalafil, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors.
Hypersensitivity
Hypersensitivity side effects have included Stevens-Johnson syndrome and exfoliative dermatitis.
Top
More Cialis resources
Cialis Detailed Consumer Information (PDR)
Cialis Prescribing Information (FDA)
Cialis MedFacts Consumer Leaflet (Wolters Kluwer)
Cialis Advanced Consumer (Micromedex) - Includes Dosage Information
Cialis Consumer Overview
Tadalafil Professional Patient Advice (Wolters Kluwer)
Adcirca MedFacts Consumer Leaflet (Wolters Kluwer)
Adcirca Prescribing Information (FDA)
Adcirca Consumer Overview. In tadalafil clinical pharmacology trials, back pain or myalgia generally occurred 12 to 24 hours after dosing and typically resolved within 48 hours. It is not possible to determine whether these events are related cialis confusion to the use of PDE5 inhibitors, to the patient's underlying vascular risk factors or anatomical defects, to a combination of these factors, or to other factors .
Otologic — Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including Cialis. In many cases, medical follow-up information was limited. The list does not include adverse events that are reported from clinical trials and that are listed elsewhere in this section.
Cardiovascular and cerebrovascular — Serious cardiovascular events, including myocardial infarction, sudden cardiac death, stroke, chest pain, palpitations, and tachycardia, have been reported postmarketing in temporal association with the use of tadalafil. A causal cialis confusion of these events to Cialis is uncertain. In some of the cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. It is not possible to determine whether these reported events are related directly to the use of Cialis, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors .
Urogenital — priapism .
Top
Side Effects by Body System
Cardiovascular
Cardiovascular side effects have included angina pectoris, chest pain, hypotension, hypertension, myocardial infarction, postural hypotension, palpitations, syncope, and tachycardia.
Dermatologic
Dermatologic side effects have included pruritus, rash, and sweating.
Gastrointestinal
Gastrointestinal side effects have included dyspepsia, diarrhea, dry mouth, dysphagia, esophagitis, gastroesophageal reflux, gastritis, loose stools, nausea, upper abdominal pain, and vomiting.
General
General side effects have included asthenia, face edema, facial flushing, fatigue, and pain in a limb.
Genitourinary
Genitourinary side effects have included increased erection and spontaneous penile erection.
Hepatic
Hepatic side effects have included abnormal liver function tests such as an increased GGTP.
Musculoskeletal
Musculoskeletal side effects have included back pain or myalgia, arthralgia, and neck pain.
Respiratory
Respiratory side effects have included nasal congestion, dyspnea, epistaxis, pharyngitis, nasopharyngitis, upper respiratory tract infection, and bronchitis.
Nervous system
Nervous system side effects have included headache, dizziness, hypesthesia, insomnia, paresthesia, somnolence, migraine and vertigo. Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of Cialis without sexual activity. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors, to the patient's underlying vascular risk factors or anatomical defects, to a combination of these factors, or to other factors .
Otologic — Cases of sudden decrease or loss cialis confusion hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including Cialis. reported for Cialis for use as needed:
Table 1: cialis confusion Adverse Events Reported by ≥2% of Patients Treated with Cialis (10 or 20 mg) and More Frequent on Drug than Placebo in the Eight Primary Placebo-Controlled Phase 3 Studies cialis confusion a Study in Patients with Diabetes) for Cialis for Use as Needed
a The term flushing includes: facial flushing and flushing
Adverse Event
Placebo
(N=476)
Tadalafil 5 mg
(N=151)
Tadalafil 10 mg
(N=394)
Tadalafil 20 mg
(N=635)
Headache
5%
11%
11%
15%
Dyspepsia
1%
4%
8%
10%
Back pain
3%
3%
5%
6%
Myalgia
1%
1%
4%
3%
Nasal congestion
1%
2%
3%
3%
Flushinga
1%
2%
3%
3%
Pain in limb
1%
1%
3%
3%
Cialis for Once Daily Use
In three placebo-controlled Phase 3 clinical trials of 12 or 24 weeks duration, mean age was 58 years (range 21 to 82) and the discontinuation rate due to adverse events in patients treated with tadalafil was 4.1%, compared to 2.8% in placebo-treated patients.
The following adverse events were reported in clinical trials of 12 weeks duration:
Table 2: Treatment-Emergent Adverse Events Reported by ≥2% of Patients Treated with Cialis for Once Daily Use (2.5 or 5 mg) and More Frequent on Drug than Placebo in the Three Primary Placebo-Controlled Phase 3 Studies at 12 weeks (Including a Study in Patients with Diabetes) for Cialis for Once Daily Use
Adverse Event
Placebo
(N=248)
Tadalafil 2.5 mg
(N=196)
Tadalafil 5 mg
(N=304)
Headache
5%
3%
6%
Dyspepsia
2%
3%
5%
Nasopharyngitis
4%
4%
3%
Back pain
1%
3%
3%
Upper respiratory tract infection
1%
3%
3%
Flushing
1%
1%
3%
Influenza
2%
3%
2%
Myalgia
1%
2%
2%
Cough
0%
4%
2%
Diarrhea
0%
1%
2%
Nasal congestion
0%
2%
2%
Pain in extremity
0%
1%
2%
Bronchitis
1%
2%
0%
Urinary tract infection
0%
2%
0%
Gastroesophageal reflux
0%
2%
1%
Abdominal pain
0%
2%
1%
The following adverse events were reported over 24 weeks treatment duration in one placebo-controlled Phase 3 clinical study:
Table 3: Treatment-Emergent Adverse Events Reported by ≥2% of Patients Treated with Cialis for Once Daily Use (2.5 or 5 mg) and More Frequent on Drug than Placebo in One Placebo-Controlled Phase 3 Study of 24 Weeks Treatment Duration for Cialis for Once Daily Use
Adverse Event
Placebo
(N=94)
Tadalafil 2.5 mg
(N=96)
Tadalafil 5 mg
(N=97)
Nasopharyngitis
5%
6%
6%
Gastroenteritis viral
2%
3%
5%
Influenza
3%
5%
3%
Back Pain
3%
5%
2%
Upper Respiratory Tract Infection
0%
3%
4%
Dyspepsia
1%
4%
1%
Gastroesophageal Reflux Disease
0%
3%
2%
Myalgia
2%
4%
1%
Hypertension
0%
1%
3%
Nasal Congestion
0%
0%
4%
Back pain or myalgia was reported at incidence rates described in Tables 1 and 2. The list does not include adverse events that are reported from clinical trials and that are listed elsewhere in this section.
Cardiovascular cialis confusion cerebrovascular — Serious cardiovascular events, including myocardial infarction, sudden cardiac death, stroke, chest pain, palpitations, and tachycardia, have been reported postmarketing in temporal association with the use of tadalafil. In many cases, medical follow-up information was limited. cialis confusion rates for Cialis for once cialis confusion use are described in Table 2. In some cases, medical conditions and other factors were reported that may have also played a cialis confusion in the otologic adverse events. A causal relationship of these events to Cialis is uncertain.
Online pharmacy Tags
Cheap Pills Online
Incidence rates for Cialis for once daily use are described in Table 2. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. In some of the cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of Cialis without sexual cialis confusion These events have been chosen for inclusion either due to their seriousness, reporting frequency, lack of clear alternative causation, or a cialis confusion of these factors. It is not possible to determine whether these reported events are related directly to the use of Cialis, to the patient's underlying cialis confusion factors for hearing loss, cialis confusion combination of these factors, or to other factors .
Urogenital — priapism .
Top
Side Effects by Body System
Cardiovascular
Cardiovascular side effects have included angina pectoris, chest pain, hypotension, hypertension, myocardial infarction, postural hypotension, palpitations, syncope, and tachycardia.
Dermatologic
Dermatologic side effects have cialis confusion pruritus, rash, and sweating.
Gastrointestinal
Gastrointestinal side effects have included dyspepsia, diarrhea, dry mouth, dysphagia, esophagitis, gastroesophageal reflux, gastritis, loose stools, nausea, upper abdominal pain, and vomiting.
General
General side effects have included asthenia, face edema, facial flushing, cialis confusion and pain in a limb.
Genitourinary
Genitourinary side effects have included increased erection and spontaneous penile erection.
Hepatic
Hepatic side effects have included abnormal liver function tests such as an increased GGTP.
Musculoskeletal
Musculoskeletal side effects have included back pain or myalgia, arthralgia, and neck pain.
Respiratory
Respiratory side effects have included nasal congestion, dyspnea, epistaxis, pharyngitis, nasopharyngitis, upper respiratory tract infection, and bronchitis.
Nervous system
Nervous system side effects have included headache, dizziness, hypesthesia, insomnia, paresthesia, somnolence, migraine and vertigo. It is not cialis confusion to determine whether these reported events are related directly to the use of tadalafil, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors.
Hypersensitivity
Hypersensitivity side effects have included Stevens-Johnson syndrome and exfoliative dermatitis.
Top
More Cialis resources
Cialis Detailed Consumer Information (PDR)
Cialis Prescribing Information (FDA)
Cialis MedFacts Consumer Leaflet (Wolters Kluwer)
Cialis Advanced Consumer (Micromedex) - Includes cialis confusion Information
Cialis Consumer Overview
Tadalafil Professional Patient Advice (Wolters Kluwer)
Adcirca MedFacts Consumer Leaflet (Wolters Kluwer)
Adcirca Prescribing Information (FDA)
Adcirca Consumer Overview.
|